1st Quarter - Report
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
Client
Income
—
Expenses
$25,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Buy America
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CASEY | Congressman John Tierney Senator Tom Carper |
| SARAH CHRISTINE D'ORSIE | Congressman Tom Davis |
Taxation/Internal Revenue Code TAX
Tax Reform, Section 199, BEAT, Gilty, Buy America
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CASEY | Congressman John Tierney Senator Tom Carper |
| SARAH CHRISTINE D'ORSIE | Congressman Tom Davis |
Pharmacy PHA
Drug pricing legislation, Biosimilars, Patent Reform, Rebate Reform, BLOCKING Act, Electronic Labeling, FDA Foreign Inspection backlog
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CASEY | Congressman John Tierney Senator Tom Carper |
| SARAH CHRISTINE D'ORSIE | Congressman Tom Davis |
Medicare/Medicaid MMM
Rebate Reform, Medicare Part D Redesign, Inflationary penalties, Drug pricing legislation, International reference pricing, Medicare direct negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CASEY | Congressman John Tierney Senator Tom Carper |
| SARAH CHRISTINE D'ORSIE | Congressman Tom Davis |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.